Balboa Wealth Partners »

Biomarin Pharma Inc convertible/ shares owned by Balboa Wealth Partners

Quarter-by-quarter ownership of Biomarin Pharma Inc convertible/ shares owned by Balboa Wealth Partners from 13F filings

Historical chart of Balboa Wealth Partners investment in Biomarin Pharma Inc convertible/

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharma Inc convertible/ held by Balboa Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharma Inc convertible/ by Balboa Wealth Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $46k 47k 0.98
2023-09-30 $46k 47k 0.98
2023-06-30 $46k 47k 0.98
2023-03-31 $54k 53k 1.01
2022-12-31 $57k 53k 1.07
2022-09-30 $57k 56k 1.02

More positions owned by Balboa Wealth Partners

Tesla Motors (TSLA)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Advanced Micro Devices (AMD)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl C (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Adobe Systems Incorporated (ADBE)
Boeing Company (BA)
Costco Wholesale Corporation (COST)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)

View all positions for Balboa Wealth Partners

Top funds holding Biomarin Pharma Inc convertible/

OZ Management
Millennium Management
Citigroup
Aviva
Two Sigma Investments
Calamos Advisors
Partner Fund Management
Bank of America Corporation
Lord, Abbett & Co
Sunrise Partners Limited Partnership
Centiva Capital
Jpmorgan Chase & Co
RWC Asset Management
MacKay Shields
Palisade Capital Management

View all funds holding Biomarin Pharma Inc convertible/